Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Laparoscopic versus robot-assisted left-sided pancreas removal for benign and premalignant lesions

Official title: Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3): an International Multicenter Patient-blinded Randomized Controlled Trial

Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06939023 · Data updated 2026-11-12

This trial will randomize adults needing elective left-sided pancreas removal for benign or premalignant lesions to laparoscopic or robot-assisted minimally invasive surgery to see if one approach leads to faster recovery and fewer complications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment256 (estimated)
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Academic / other
Locations1 site (Amsterdam)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJune 1, 2027
Study endsJune 1, 2028
Registry record updatedSeptember 4, 2025
Trial IDNCT06939023 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with benign or premalignant lesions in the pancreas body or tail who are fit for elective left-sided pancreatectomy, for whom both laparoscopic and robot-assisted approaches are technically feasible, and who provide informed consent.

Probably not a fit

Patients with suspected pancreatic ductal adenocarcinoma, tumors larger than 8 cm, major vascular involvement, need for resection/ablation of other organs, pregnancy, BMI >40 kg/m2, or participation in conflicting trials are excluded and unlikely to benefit from this comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The DIPLOMA-3 trial is an international, multicenter, patient-blinded randomized controlled comparison of laparoscopic and robot-assisted left-sided pancreatectomy for benign or premalignant lesions in the body or tail of the pancreas. Eligible adults are randomized to undergo either laparoscopic or robot-assisted minimally invasive resection, with both spleen-preserving and non-preserving procedures allowed where appropriate. Surgeons must deem both approaches technically feasible for each patient, and standard perioperative care and follow-up protocols are applied across participating centers. Outcomes focus on perioperative complications, recovery metrics, and surgical safety to determine whether one minimally invasive approach has clinical advantages.

Why it matters

Potential benefit: If successful, the trial could clarify whether robot-assisted or laparoscopic techniques lead to fewer complications, quicker recovery, or better spleen preservation after left-sided pancreas removal.

How similar studies have gone: Laparoscopic distal pancreatectomy has demonstrated safety and effectiveness in prior studies and robot-assisted techniques have encouraging observational results, but randomized evidence directly comparing the two approaches is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age at least 18 years;
* Indication for elective left-sided pancreatectomy, either spleen-preserving or non-preserving (because of proven or suspected left-sided benign or premalignant disease);
* Both robot-assisted and laparoscopic left-sided pancreatectomy are technically feasible for resection, according to the local treatment team;
* Fit to undergo left-sided pancreatectomy according to the surgeon and anaesthesiologist;
* Written informed consent

Exclusion Criteria:

* Suspected pancreatic ductal adenocarcinoma;
* Tumor or cyst larger than 8 cm;
* Required resection or ablation of organs other than pancreas and spleen;
* Tumor involvement or abutment of major vessels (celiac trunk, mesenteric artery or vena cava);
* Pregnancy;
* Body mass index \>40 kg/m2;
* Participation in another study with interference of study outcomes

Where it's running

  • Amsterdam UMC
    Amsterdam, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.